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Rhythms in female reproduction are critical to insure that timing of ovulation coincides 
with oocyte maturation and optimal sexual arousal. This fine tuning of female reproduc-
tion involves both the estradiol feedback as an indicator of oocyte maturation, and the 
master circadian clock of the suprachiasmatic nuclei (SCN) as an indicator of the time 
of the day. Herein, we are providing an overview of the state of knowledge regarding the 
differential inhibitory and stimulatory effects of estradiol at different stages of the repro-
ductive axis, and the mechanisms through which the two main neurotransmitters of the 
SCN, arginine vasopressin, and vasoactive intestinal peptide, convey daily time cues to 
the reproductive axis. In addition, we will report the most recent findings on the putative 
functions of peripheral clocks located throughout the reproductive axis [kisspeptin (Kp) 
neurons, gonadotropin-releasing hormone neurons, gonadotropic cells, the ovary, and 
the uterus]. This review will point to the critical position of the Kp neurons of the antero-
ventral periventricular nucleus, which integrate both the stimulatory estradiol signal, and 
the daily arginine vasopressinergic signal, while displaying a circadian clock. Finally, given 
the critical role of the light/dark cycle in the synchronization of female reproduction, we 
will discuss the impact of circadian disruptions observed during shift-work conditions on 
female reproductive performance and fertility in both animal model and humans.
Keywords: female reproduction, circadian clock, suprachiasmatic nuclei, kisspeptin, GnRH, LH, estradiol, 
shift-work
introduction
Ovulation in female mammals is a complex process, which is exquisitely regulated by a number of 
environmental (time of day, time of year, food resources, and stress level) and internal (development 
stage, hormonal milieu, and metabolic rate) factors. Indeed, female reproduction is a long-term, 
demanding process and therefore, it is important that a limiting critical status is reached to ensure 
successful reproductive outcome. In adult females where all these criteria are attained, there are 
still two important cues that time ovulation: the circulating level of gonadal hormones, specifically 
estradiol, which is an indicator of oocyte maturation, and the time of day arising from biological 
clocks. This dual regulation ensures that the timing of ovulation coincides with the period of maximal 
activity and sexual motivation. Most mechanistic studies aimed at understanding this subtle timing 
of ovulation have been performed in laboratory rodents, but ovulation in humans is also gated by 
similar hormonal and circadian inputs. Hence, this review will not only focus on the mechanisms 
regulating the timing of reproduction in female rodents, but will also discuss human female fertility, 
including the desynchronization associated with modern life styles (shift work, jet lag, and sleep 
alteration).
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Female Reproduction is Rhythmic
Reproductive activity in female mammals displays a regular cycle 
(menstrual cycles in women, estrous cycles in rodents) driven 
by a complex interaction of the circadian system, hypothalamic 
neuropeptides, gonadotropins [luteinizing hormone (LH) 
and follicle-stimulating hormone (FSH), both secreted by the 
pituitary gonadotroph cells], and sex steroid hormones produced 
by the ovaries. The final output of this regulatory process is to 
combine the production of a mature oocyte (ovulation) with 
a receptive reproductive tract, which will ensure the embryo’s 
development.
During the first part of the reproductive cycle (follicular phase 
in women; metestrus–diestrus in rodents), gonadotrophs produce 
more FSH than LH. This relative FSH preponderance contributes 
to the recruitment and development of ovarian follicles. FSH 
promotes follicular growth leading to a progressive increase of the 
sex steroid hormone, estradiol, and increases LH receptor expres-
sion in granulosa cells (1). During this early phase, LH pulses 
occur with a high frequency (period of 1–2 h in women, 20 min 
in rodents) and uniform amplitude, and the pulse frequency 
tends to increase toward the end of the phase. The second part of 
the reproductive cycle (luteal phase in women; proestrus–estrus 
in rodents) begins with a marked and transient secretion of LH 
(Figures 1A,D). The LH surge has three functions: (1) induction 
of ovulation of mature follicles, (2) resumption of oocyte meiosis, 
and (3) arrest of granulosa cell proliferation and luteum induction. 
After the LH surge, ovulation generally follows a few hours later 
in rodents, and 24–48 h in women. The preovulatory LH surge 
takes place approximately every 4–5 days in rodents and every 
28 days in women and its occurrence depends on high circulating 
estradiol levels (2, 3). Additionally, the LH surge requires a daily 
signal since it arises at a very specific time of day, usually at the 
end of the resting period, thus in the late afternoon in nocturnal 
rodents and the end of the night/early morning in the diurnal 
rodent Arvicanthis (4) and in humans (5–7). Indeed, in 80% of 
women, the LH surge occurs around 8 a.m. At the end of the 
reproductive cycle, LH pulse frequency decreases significantly 
down to a pulse interval of 2–6 h with variable amplitude (8).
The secretion of both LH and FSH is under the control of a 
hypothalamic neurohormone, gonadotropin-releasing hormone 
(GnRH), which is synthesized in neurons scattered throughout 
the preoptic area (POA) and the organum vasculosum laminae 
terminalis. These neurons project to the median eminence where 
they release GnRH in the portal circulation in a pulsatile manner. 
GnRH activates specific receptors located on pituitary gonado-
trophs inducing the synthesis and release of LH and FSH. GnRH 
is essential for reproduction as mutations in the gene coding for 
GnRH (10) and GnRH receptor (11) are proposed to be responsi-
ble for idiopathic hypogonadotropic hypogonadism (IHH), char-
acterized by delayed puberty and infertility (11). The pulsatility of 
GnRH release is critical to induce proper gonadotropin secretion, 
and there is a tight correlation between GnRH and LH pulsatili-
ties. Pulsatile administration of exogenous GnRH (one pulse per 
hour) is capable of restoring the preovulatory surge, ovulation, 
and normal menstrual cycles in patients suffering from Kallmann 
syndrome (12, 13). In contrast, continuous GnRH administration 
induces a reversible blockage of the pituitary gonadotroph cells’ 
secretion (14).
Various (neuro)transmitters had been proposed to regulate 
GnRH neuronal activity until the neuropeptide kisspeptin (Kp) 
was discovered as a potent activator of GnRH release. In 1996, the 
Kiss1 gene was discovered and reported to encode a peptide called 
metastin, because of its anti-metastatic property on malignant 
melanoma cells (15). However, the receptor of this peptide, GPR54, 
was later found to play a critical role in reproductive physiology 
when two groups reported that mutation of the GPR54 receptor 
results in IHH in humans, with an identical phenotype observed 
in mice with a targeted deletion in this receptor (16, 17). The Kiss1 
gene was shown to encode a family of Kps from an initial 145 
amino acid propeptide, Kp-145, which is cleaved into peptides of 
different sizes from Kp-54 (previously named metastin) to Kp-10. 
The discovery of Kp’s role in reproductive function has been a 
milestone in the field of reproductive biology, and numerous 
studies now indicate that Kps are critical regulators of sexual dif-
ferentiation and maturation as well as of normal adult reproduc-
tive functioning across mammalian species, including humans 
(18). Kp neurons are localized within two hypothalamic areas, in 
the arcuate nucleus (ARN) and the rostral periventricular nucleus 
of the third ventricle, also called anteroventral periventricular 
nucleus (AVPV), or the preotic area (according to species). They 
send projections mainly to the GnRH neuron cell bodies (AVPV 
Kp neurons) and nerve terminals [ARN Kp neurons (19–22)] 
(Figure 1A). The AVPV presents a marked sexual dimorphism, 
with more Kp neurons in females as compared to males (20, 23). 
The AVPV Kp neurons are the main drivers of the preovulatory 
GnRH/LH surge (24). In contrast, the ARN Kp neurons are not 
sexually dimorphic (20, 23). The Kp receptor, Kiss1R (formerly 
GPR54), is highly expressed in GnRH neurons but also in other 
brain areas (25, 26) and in most endocrine tissues like the pituitary 
gland, ovary, and placenta (27). Kp has a very potent stimulatory 
action on GnRH release and, therefore, gonadotropin secretion in 
all mammalian species investigated so far (18, 19, 28, 29). Central 
injection of doses as low as 0.1–1 pmol Kp10 is indeed sufficient 
to evoke robust LH secretion in rats and monkeys (28, 30). Kp 
injections must be short and at least 2 h apart to induce the LH 
peak since the repeated administration of Kp induces Kiss1R 
desensitization (31, 32). Notably, Kp release in the stalk-median 
eminence is pulsatile (33), and pulsatile Kp drives LH secretion 
in juvenile monkeys (34). A recent study reported that pulsatile 
administration of Kp was able to evoke dramatic synchronous 
activation of GnRH gene transcription with robust stimulation of 
GnRH secretion in murine-cultured hypothalamic explants (35). 
The preeminent phenotypes of impaired reproduction (abnormal 
sexual maturation, small uterus, ovaries without mature follicles, 
no estrous cycles) often arise from mutations in Kiss1 (36, 37) and 
Kiss1R (16, 38, 39), which suggest that the Kiss1/Kiss1R complex 
is essential for the central regulation of the gonadotropic axis.
Other classical neurotransmitters and neuropeptides have 
been reported to regulate GnRH neuron activity albeit not to the 
same extent as Kp. GABA and glutamate fibers are found close to 
GnRH perikarya in the POA and axons in the median eminence. 
Both neurotransmitters have been shown to play a role in the 
regulation of GnRH release. Glutamate stimulates Gnrh gene 
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FiGURe 1 | The multi-oscillatory network of the female hypothalamic–pituitary gonadal axis in rodents. (A) Schematic representation of the 
neuroendocrine pathway timing female reproduction: the master circadian clock located in the hypothalamic suprachiasmatic nucleus (SCN) is synchronized 
to the daily cycle mostly via the light/dark cycle and to a less extend by other time cues (food intake and sleep/wake activity); two SCN peptidergic 
transmitters forward the daily information to the reproductive axis: arginine vasopressin (AVP) is the most essential daily transmitter projecting to the 
kisspeptin (Kp) neurons of the anteroventral periventricular nuclei (AVPV), which in turn strongly activate the GnRH neurons located in the preoptic area 
(POA); vasoactive intestinal peptide (VIP) directly modulates GnRH neuron activity and possibly indirectly via neurons of the dorsomedial hypothalamus 
(DMH), which express RF-related peptide (RFRP); GnRH released in the portal blood system activates the synthesis and release of the gonadotropins 
luteinizing hormone (LH) and folliculo-stimulating hormone (FSH), which in turn regulate oocyte maturation, estradiol synthesis, and finally ovulation triggered 
by the LH surge; throughout the estrous cycle, estradiol feeds back onto different levels of the reproductive axis principally via the nuclear estrogen receptor 
α (ERα) and to a less extend via ERβ. Kp neurons are the main estradiol targets with an inhibitory effect of low estradiol on Kp neurons of the arcuate 
nucleus (ARN) and a stimulatory action of high estradiol on AVPV Kp neurons. In addition to the master SCN clock, peripheral clocks are located in the 
AVPV Kp neurons, GnRH neurons, pituitary gonadotrophs, and the different cell types of the ovary. (B) Representative pictures showing PER1 
immunoreactivity (green) in Kp immunoreactive neurons (red) in the AVPV of female mice sampled at zeitgeber time 20 (8 h after lights off on a 12 h 
light/12 h dark schedule) on the day of proestrus [adapted from Ref. (9)]. (C) Representative bioluminescence traces from isolated AVPV explants of 
PER2:LUCIFERASE female mice, in absence (0 E2, light gray line) or in presence of estradiol (1 μM E2, black line) in the culture medium; τ indicates the 
period of the circadian AVPV oscillations in both conditions [adapted from Ref. (9)]. (D) Schematic representation of the mouse estrus cycle including the 
four stages: metestrus, diestrus, proestrus (the stage at which the LH concentration raises as an LH surge), and estrus; during the first part of the 
reproductive cycle, low circulating level of estradiol displays a negative feedback, whereas at proestrus, high estradiol levels exert a positive feedback, 
causing a synchronized activation of GnRH neurons leading to the preovulatory surge of LH; notably, the LH surge occurs at the end of the resting period, 
which is late day in nocturnal species.
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expression and GnRH release during the LH surge, whereas a glu-
tamate antagonist blocks Gnrh gene expression and the LH surge 
when administered in the morning (40–42). Administration of 
an AMPA agonist enhances the in vivo LH secretion in OVX rats 
only with estradiol substitution, whereas glutamate stimulates 
in vitro GnRH secretion in a estradiol-independent matter (43). 
The role of GABA on GnRH neuronal activity is debated since 
inhibitory and stimulatory effects have been observed depending 
on the protocols used, the presence of sex steroid treatment, the 
timing in the estrus cycle and the hypothalamic region studied 
(44, 45). Fibers containing the orexigenic neuropeptide Y contact 
a majority of GnRH neurons, which express neuropeptide Y 
receptors. This neuropeptide has been reported to exert variable 
effects depending on the metabolic and reproductive status of the 
animal, but most of the studies describe an inhibitory effect of 
neuropeptide Y on GnRH neurons (46–48). Recent studies indi-
cate that another neuropeptide belonging to the same RF-amide 
peptide family as Kp, RFRP-3 (the mammalian homolog of avian 
gonadotropin-inhibitory hormone), regulates GnRH neuron 
activity [for review, see Ref. (49–51)]. Unlike Kp, RFRP-3 can 
activate or inhibit the reproductive axis according to gender, 
species, and environmental conditions (26, 51–53). In female 
rodents RFRP neuronal activity is decreased at the time of the 
LH surge, possibly to relieve the inhibitory effect of RFRP-3 on 
GnRH neurons (54). However, mice bearing a null mutation of 
GPR147, the RFRP-3 receptor, present only a mild reproductive 
phenotype (55).
estrogenic Regulation
Estradiol produced by the ovaries exerts both positive and 
negative feedback upstream of the reproductive axis, modulating 
GnRH neuron activity and anterior pituitary gonadotroph cells. 
During the first part of the reproductive cycle, estradiol induces 
a negative feedback, whereas when estradiol concentration is the 
highest (at the end of the follicular phase in humans or proestrus 
in rodents) the feedback becomes positive, causing a synchro-
nized activation of GnRH neurons leading to GnRH release in 
the hypophyseal portal blood and finally the preovulatory LH 
surge (56) (Figures 1A,D). The effect of estradiol is mediated via 
two types of nuclear estrogen receptors (ERs), which induce long 
lasting genomic action, ERα and ERβ (57, 58), but it can also have 
a rapid action via membrane bound estradiol receptors, including 
the GPR30 (59, 60).
GnRH Neurons
Gonadotropin-releasing hormone neurons contain few, if any, ERα 
(61–63), but do express ERβ (64–66) and GPR30 (67). Estradiol 
application to cultured primate GnRH neurons induces a rapid 
increase in action potential firing frequency (68) and intracellular 
calcium oscillations (69). Similar effects have been reported in 
the mouse GnRH neurons (70). This rapid effect of estradiol is 
proposed to be mediated via GPR30 in primates (67) and ERβ in 
mice (70, 71). Using an in vitro GnRH neuronal model, the GT1-7 
cells, it was reported that Kiss1R expression is estradiol depend-
ant, with a Kp-induced GnRH increase only in cells treated with 
estradiol (72, 73). A primary effect of estradiol on GnRH neurons 
has been hypothesized to upregulate expression of channel tran-
scripts (TRPC4 channels and HCN1 channels) that orchestrate 
the downstream signaling of Kiss1R in GnRH neurons (74, 75). 
Therefore, estradiol could be a potent regulator of ion channel 
and receptor expression in GnRH cells, hence controlling the sen-
sitivity of GnRH neurons to Kp. However, a recent study reported 
that mutant mice with a GnRH neuron-selective deletion of ERβ 
exhibit normal cycles and negative feedback, leaving the critical 
role for ERβ in GnRH neuron activity still an open question (76).
Kisspeptin Neurons
In contrast to GnRH, Kp neurons have a high density of ERα 
and are, therefore, considered as the intermediate node for the 
estradiol feedback on GnRH neurons (19, 20, 32, 61, 77–79) 
(Figure  1A). Interestingly, the estradiol feedback in rodents 
depends on the Kp neuron localization as estradiol stimulates 
Kiss1 expression in the AVPV and inhibits Kiss1 expression in the 
ARN (77, 80–82). In non-rodent mammals, a similar differential 
regulation by estradiol is also observed with a stimulatory effect 
in the rostral periventricular/POA and an inhibitory effect in the 
ARN (83, 84). The mechanism underlying these differences in the 
regulation of Kiss1 expression by ERα in both structures is not 
yet fully understood. AVPV Kiss1 activation requires an estrogen 
response element (ERE)-dependent pathway, whereas inhibi-
tion of Kiss1 expression in the ARN involves ERE-independent 
mechanisms (80, 85). Recent studies have reported that estradiol 
additionally modulates daily activity of AVPV Kp neurons. Hence, 
the daily variation in c-Fos activation, Kiss1 mRNA and peptide 
content observed in proestrus or in ovariectomized estradiol-
treated rodents is abolished or strongly reduced in diestrus or in 
ovariectomized animals (9, 86–88). Furthermore, estradiol has 
been reported to increase the number of arginine vasopressin 
(AVP) synaptic contacts onto Kp neurons (89), regulate AVP1a 
receptor expression by Kp neurons (88) and be permissive for the 
AVP-induced electrical activation of Kp neurons (90). Altogether 
these observations indicate that high circulating levels of estradiol 
gate the action of AVP onto AVPV Kp neurons (see Role of the 
Suprachiasmatic Nuclei for the role of AVPV on Kp neurons).
Circadian System
Estradiol is also suggested to influence daily functions since shifts 
are observed during the pubertal period, pregnancy, menopause, 
and throughout the reproductive cycle (91–93). In rodents, ERα 
and ERβ are expressed in the retina, the retino-hypothalamic 
tract, the geniculohypothalamic tract and raphe nuclei-derived 
serotonergic inputs, all major inputs to the suprachiasmatic 
nuclei (SCN), which contain the master circadian clock (94). 
In mice, the second half of the proestrus night is often, but not 
consistently, characterized by increased motor activity compared 
to the remaining nights of the estrous cycle (95, 96). Furthermore, 
ovariectomy reduces total motor activity, and estradiol reverses 
this effect, while also shortening the length of the free running 
period and advancing the onset of wheel running activity (96). 
Estradiol may act directly on SCN clock gene oscillation since 
estradiol treatment in ovariectomized rats decreased Cry2 mRNA 
levels (97) and estradiol application to SCN slices increased the 
spontaneous firing frequency and depolarized cell membranes 
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of the SCN neurons (98). However, other studies reported that 
estradiol treatment of SCN explants from PER2:LUCIFERASE 
mice has no effect on the period and amplitude of the circadian 
oscillations (9, 99). Alternatively, estradiol may alter rhythms 
in running activity via indirect effects on the medial POA or 
striatum (100, 101).
Pituitary
Pituitary gonadotrophs express ERα, and estradiol has been pro-
posed to exert a direct negative feedback effect on gonadotropin 
secretion (102–104). Chronic treatment with estradiol induces 
negative feedback effects on gonadotrophin secretion after GnRH 
supraphysiologic stimulation in ewes (105) or humans (106). 
Interestingly, a recent study reported that mice with a selective 
deletion of ERα in pituitary gonadotroph cells had elevated serum 
LH and estradiol values, and displayed irregular estrous cycles 
punctuated by prolonged periods of disorganized cycling, point-
ing to ERα participation in the estradiol negative feedback at the 
pituitary level (107). It is worth mentioning that this phenotype 
was much less severe than the one observed after a total ERα 
deletion. Although the role of Kiss/Kiss1R at the pituitary is still 
the subject of debate, it is interesting to note that the activation 
of pituitary ERα up-regulates Kiss1 expression, whereas chronic 
exposure to estradiol down regulates Kiss1R expression on pitui-
tary gonadotrophs (108).
Uterus
The uterus expresses high levels of ERα, and is an important site 
for the estrogenic control of reproductive physiology (109, 110). 
Estradiol, together with progesterone, regulates uterine growth 
and differentiation, which in turn control embryo-endometrial 
interactions during early pregnancy (110). Furthermore, estra-
diol treatment also shortens the period of the circadian clock in 
the uterus (99).
Daily and Circadian Regulations
Role of the Suprachiasmatic Nuclei
The Hypothalamic Suprachiasmatic Nuclei Host the 
Master Biological Clock
Most biological functions, including female reproduction, are 
synchronized to the daily variation of environmental factors. 
Among these factors, the recurring light/dark cycle is the most 
predictable environmental cue used by mammals to adjust their 
behavior and physiology appropriately. The mechanisms by 
which light and dark synchronize biological functions involve 
the master biological clock located in the hypothalamic SCN and 
a retino-hypothalamic tract, which forwards the non-visual light 
to the SCN.
The demonstration that a biological clock located in the basal 
hypothalamus was driving circadian rhythms came from experi-
ments showing that SCN lesions in rodents abolished circadian 
rhythms in locomotor activity, which were restored following 
exogenous SCN implants (111, 112). The circadian activity 
of SCN neurons relies on a complex molecular system cycling 
endogenously with a period of about 1  day (circa dies). This 
molecular clockwork is composed of transcription–translation 
loops, which are now well described (113, 114). Dimers of the 
CLOCK and BMAL1 proteins bind to a specific E-box promoter 
to induce the transcription of four clock genes Per1, Per2, Cry1, 
and Cry2, which after translation produce proteins which form 
dimers to repress their own transcription by competing with the 
CLOCK/BMAL1 binding. Following degradation of the inhibi-
tory proteins, the transcription–translation loop starts over for 
another circadian cycle. When SCN explants or dissociated cells 
are kept in vitro, the endogenous circadian oscillations continue for 
weeks or months, providing that the culture medium gets enough 
nutrients and oxygen for the cell metabolism. A very interesting 
animal model used to demonstrate these sustained endogenous 
oscillations is the PER2:LUCIFERASE mice, where the expres-
sion of the luciferase gene is driven by the Per2 promoter (115, 
116). When explants or dissociated cells of PER2:LUCIFERASE 
mouse SCN are placed in a culture medium containing luciferine, 
the rhythmic expression of PER2 drives a rhythmic expression of 
luciferase, which by oxidizing luciferin causes the emission of a 
bioluminescent signal with a circadian period.
In order to achieve its role in adjusting biological functions 
with the astronomical daily cycles, the SCN circadian activity 
has to be synchronized with the time of day and transmit this 
timing information to the rest of the body. Light has long been 
known to be the main synchronizer of the SCN circadian clock, 
but interestingly it uses a specific non-visual pathway, which 
includes melanopsin-containing intrinsically photosensitive 
retinal ganglion cells projecting directly to the SCN (117, 118). 
Upon light activation, these ganglion cell terminals release glu-
tamate and pituitary activating cAMP peptide, which change the 
phase (synchronizes) of the circadian clock. The synchronizing 
property of light depends on the time of application during the 
day, and the characteristics of the phase responses depend on 
species. The astronomical light/dark alternation synchronizes 
the circadian clock in order to attain a daily rhythm of a precise 
24-h period. The CLOCK/BMAL1 dimers not only activate 
canonical clock gene expression, but other clock-controlled 
genes whose promoters display E-boxes and therefore undergo 
rhythmic expression. This mechanism was first demonstrated for 
the gene encoding AVP, an important output of the SCN clock 
(119). Levels of SCN AVP mRNA are markedly higher during the 
day than at night, but in Clock KO mice the SCN AVP rhythm is 
strongly dampened (120).
SCN Lesion or Clock Gene Mutations Alter the 
Reproductive Cycle
Various experiments aiming at impairing clock function were 
performed to delineate whether functional SCN neurons are 
required for the daily timing of the LH surge, mostly in female 
rodents. Early experiments of SCN lesions (121) or SCN-POA 
neuronal connection cut (122) resulted in an impaired LH 
surge and estrous cyclicity in female rats. Furthermore, female 
mice carrying mutations of Clock or Bmal1 displayed disrupted 
estrous cycles (123–127). Clock−/− mutant mice, for example, 
have extended and disrupted estrous cycles under both a light/
dark cycle and during continuous darkness. In humans, it was 
reported that women with single-nucleotide polymorphisms 
in the ARNTL (Bmal1) have more miscarriages and less 
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pregnancies than those without (128). Although these experi-
ments have pointed to a crucial role of the SCN in the proper 
timing of estrous cyclicity, reproductive impairment following 
clock gene mutations could as well result from peripheral clock 
desynchronization (see Other Clocks in the Reproductive 
System). Interestingly, the reproductive phenotypes of young 
Clock-, Bmal1-, or Per1/Per2-mutated mice resemble that 
of middle-aged (over 10-month old) wild-type mice, with 
increased length and decreased frequency of estrous cycles (129, 
130). These observations indicate that alterations in central or 
peripheral clocks may lead to advanced reproductive senescence 
(130).
The preovulatory LH surge is initiated by a SCN-derived 
stimulatory signal, at a time closely preceding general activity 
onset. However, this signal is effective at stimulating GnRH neu-
rons to produce the LH surge only when estradiol concentrations 
have reached a critical threshold. Prior to the day of proestrus, the 
developing ovarian follicles secrete insufficient estradiol to fulfill 
this criteria and therefore, the SCN signal does not trigger the LH 
surge (56). The occurrence of the daily stimulatory SCN signal 
can be unmasked by implanting female rodents with estradiol 
capsules that result in proestrus concentrations of this hormone; 
in this case, a LH surge occurs every day (3, 56, 131).
SCN Neuropeptides Involved in the Timing of the 
GnRH/LH Surge
Transplant of fetal SCN tissue into bilaterally SCN-lesioned 
hamsters restores locomotor, but not endocrine rhythms in 
the absence of neural outgrowth, suggesting that intact neural 
connections are required for endocrine rhythmicity, whereas 
behavioral rhythms can be supported by a diffusible signal (132). 
Neuroanatomical studies have pointed to two putative SCN neu-
ral outputs signaling daily information to the reproductive axis, 
AVP and vasoactive intestinal peptide (VIP). Early experiments 
have identified SCN-originating, VIP-containing fibers contact-
ing GnRH neurons (133, 134), which express the VIP receptor 
VPAC2 (135). However, more recent studies indicate that the 
SCN signals the time of day to GnRH neurons indirectly via AVP 
fibers projecting to the Kp neurons of the AVPV (78, 89).
Anterograde tracing studies show that a number of AVP-
containing axons originating in the SCN make appositions to 
Kp neurons, whereas very few or no VIP terminals were found 
apposed to Kp neurons (87, 89). Furthermore, AVP is released 
with a peak coinciding with the onset of the LH surge (136) and 
AVPV Kp neurons express V1a receptors (87). Interestingly, the 
AVP input to Kp neurons is sensitive to estradiol since estradiol 
treatment significantly increases the number of AVP terminal 
appositions on individual Kp neurons (89) and circadian expres-
sion of V1a mRNA is abolished in ovariectomized animals 
(88). Furthermore, AVP signaling onto Kp neurons is critically 
dependent on circulating estradiol as AVP no longer activates Kp 
neurons in ovariectomized mice, an effect that is fully restored 
by estradiol treatment (90). Altogether, these results are consist-
ent with the hypothesis that Kp neurons located in the rodent 
AVPV receive daily information from the SCN via an AVPergic 
monosynaptic pathway, a signal which is modulated (gated) by 
circulating estradiol (Figure 1A).
In line with these neuroanatomical observations, earlier 
physiological experiments pointed to a functional role of AVP in 
the GnRH/LH surge timing, even though the importance of Kp 
neurons was not yet known. Inhibition of AVP signaling with a 
V1a antagonist resulted in a reduction in the estradiol-induced 
LH surge (137), while intracerebroventricular infusion of AVP in 
SCN-lesioned, ovarectomized, and estradiol-treated rats was able 
to induce an LH surge (138). Furthermore, in co-cultures of POA 
and SCN, the GnRH surge was coordinated with the rhythm in 
AVP, but not VIP, and administration of AVP, not VIP, to preoptic 
explants in the presence of estradiol significantly increased GnRH 
release, providing further evidence for an important role of AVP 
in the LH surge generation (139). Finally, a recent study reported 
that intracerebroventricular administration of AVP in female 
Syrian hamsters activates Kp neurons similarly in the early or late 
part of the day, while in the same animals GnRH neurons are 
activated only late in the day (87). This observation was further 
confirmed by in vitro electrophysiological recordings of Kp-GFP 
neurons showing that AVP increases the firing rate of most Kp 
neurons during proestrus, independently of the time of day (90). 
Altogether these findings indicate that AVP activates Kp neurons 
every day, and the daytime gating of the GnRH/LH surge does 
not take place through SCN AVP–AVPV Kp signaling but rather 
downstream at the AVPV Kp–POA GnRH signaling.
A significant role of the SCN-derived VIP output in female 
reproduction should not be excluded (Figure 1A). Indeed, VIP 
afferents on GnRH neurons are sexually dimorphic, with female 
rats exhibiting higher VIPergic innervation than males (134). 
Furthermore, central administration of VIP antiserum reduces 
the LH surge (140), while central infusion of VIP is able to rescue 
the LH surge in middle-aged female rats (141). Finally, blocking 
the VPAC2 receptor attenuates GnRH neuronal cell firing during 
the afternoon surge in female, estradiol-treated mice (142). A 
recent study reported that the SCN-derived VIP neurons project 
to RFRP-3 neurons and central administration of VIP markedly 
suppresses RFRP-3 cellular activity in the evening, but not the 
morning, therefore indicating a specific role of VIP on neurons 
expressing RFRP-3, a neuropeptide thought to participate in the 
circadian-timed removal of estradiol negative feedback (143).
Other Clocks in the Reproductive System
It has long been thought that the SCN-driven outputs are the sole 
source forwarding circadian signals to the female reproductive 
system. However, a growing body of evidence now suggests that 
structures and organs that are part of the gonadotropic axis might 
also play an intrinsic role in the timing of female reproduction.
In mammals, the timing system is now described as a mul-
tioscillator hierarchy of coordinated and synchronized cell and 
tissue clocks (144). The use of Per1-luc transgenic rats (145) and 
Per2:LUCIFERASE transgenic mice (115), where the Per1 or Per2 
promoter drives expression of the luciferase gene, was decisive for 
the demonstration that non-SCN central structures and periph-
eral organs can sustain endogenous circadian oscillations. Thus, 
central structures (e.g., olfactory bulb, ARN, and retrochiasmatic 
area) and peripheral organs (e.g., liver, lung, heart, and kidney) 
are able to display endogenous-sustained circadian rhythmicity. 
The phase and the period of these “peripheral” clocks are tissue 
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characteristic and different from those of the “central” clock of the 
SCN. The strength of their endogenous oscillations is often lesser 
than that of the SCN since according to tissues (and transgenic 
mice) the oscillations last from 2 to 20 cycles on average, whereas 
those of SCN can last several months. The oscillations generated 
by the peripheral clocks are independent of the SCN activity 
(they persist in SCN-lesioned animals) but their rhythms appear 
synchronized by the master clock, which is sometimes referred 
to as the conductor of the organism’s multi-oscillatory network. 
In the context of such a complex circadian network, recent evi-
dence now suggests that the hypothalamo-pituitary gonadal axis 
is also a functional multi-oscillatory axis. Indeed, reproductive 
tissues from hypothalamic Kp and GnRH neurons down to the 
ovaries and the uterus display endogenous circadian oscillations 
of clock genes, as explained below. However, the functional 
role of these reproductive clocks with regards to the timing of 
reproduction (ovulation, implantation, and parturition) has yet 
to be determined.
Kisspeptin Neurons
Daily and circadian activities of Kp neurons in the AVPV area 
have been investigated in female rodents because of their strategic 
position between the integration of SCN-derived AVP input on 
one hand (87, 89) and the triggering of the preovulatory GnRH/
LH surge on the other (19). Additionally, the modulatory effect 
of circulating estradiol on the daily activity of Kp neurons has 
also been investigated because of the potent effect of estradiol on 
Kp synthesis (77). Under high circulating estradiol levels, either 
in proestrus or in ovariectomized  +  estradiol-supplemented 
rodents, Kp neuronal activity (as seen by c-FOS activation) and 
Kiss1 mRNA are significantly increased about 3 h before lights 
off, thus 2  h before the LH surge (9, 86–88). Furthermore, we 
recently reported that Kp immunoreactivity is markedly but 
transiently decreased at the same time (9). In contrast, in low 
circulating estradiol conditions, in diestrus or ovariectomized 
animals, the daily variation in neuronal activity, Kiss1 mRNA 
and Kp immunoreactivty is abolished or strongly dampened (9, 
86, 88). The daily activation of Kp neurons is triggered by the 
SCN AVP input since central injection of AVP induces c-FOS 
in Kp neurons and increases Kiss1 mRNA (87). Although AVP 
is released from the SCN neurons in the afternoon (146), AVP 
can activate Kp neurons in the morning or in the afternoon, 
indicating that the daily control of the LH surge is not gated by the 
AVPV Kp neurons (87). A recent study recording Kp neuron elec-
trical activity confirmed that Kp neuron responsiveness to AVP 
depends on the concentrations of estradiol (90). Altogether these 
data indicate that under high circulating estradiol (when oocytes 
are mature enough to be released), Kp neurons can be activated 
by the SCN-derived AVP to increase Kp synthesis and release in 
order to induce GnRH neuronal activation and the downstream 
LH surge. In addition to the AVP activation of Kp neurons, we 
recently reported that these neurons host an intrinsic circadian 
clock, named Kiss-Clock (9). A preliminary study reported that 
the clock genes Per1 and Bmal1 are expressed in the rat AVPV, 
but their cellular localization was not established (88). We further 
demonstrated that virtually all AVPV Kp neurons express the 
PER1 protein (Figure 1B) with a daily rhythm both in proestrus 
and diestrus, but with a phase delay of about 3 h in diestrus as 
compared to proestrus (9). Furthermore, we reported that iso-
lated Kp-expressing AVPV explants from PER2:LUCIFERASE 
mice display endogenous circadian oscillations with a period of 
23.2  h (thus 1  h shorter than the SCN circadian period of the 
same mice), confirming the presence of an intrinsic circadian 
oscillator in AVPV Kp neurons (9) (Figure 1C). Remarkably, the 
period of this circadian clock is increased by 1 h in the presence 
of estradiol in the culture medium (Figure 1C), which is in line 
with the observed phase difference in PER1 expression according 
to the estrous stage. In contrast, the period of the SCN clock is 
not altered by environmental estradiol either in vivo or in vitro 
(9). The role of this Kiss-Clock has yet to be established. However, 
according to previous studies one might hypothesize that it could 
time sensitivity to estradiol since ERα gene expression can be 
regulated by the BMAL1/CLOCK dimer (147), or it could also 
impact Kiss1 gene expression since a circadian transcriptional 
factor, albumin D-site binding protein (Dbp), was reported to 
trigger Kiss1 transcription via the D-box (148).
GnRH Neurons
Because of their pulsatile activity and critical role in timing 
the LH surge, GnRH neurons were the first in the reproductive 
system to be reported to express clock genes and display circadian 
activity. Indeed, all core clock genes (Clock, Bmal1, Per1/2, and 
Cry1/2) are expressed and cycle with a circadian period in both 
GT1-7 GnRH neuronal cell lines and GnRH neurons (149–152). 
Disruption of the circadian clock by transient expression of Clock 
Δ 19 in GT1-7 cells decreases the GnRH pulse frequency, while 
overexpression of Cry1 in the same cells increases GnRH pulse 
amplitude (149). The GnRH clock could also regulate the tim-
ing of the neuronal sensitivity to upstream inputs. Indeed, the 
ability of VIP to activate GnRH neurons depends on the time of 
day and the estradiol environment (153), and the sensitivity of 
GT1-7 cells to release GnRH upon Kp or VIP treatment is time 
dependent (151). This time-dependent sensitivity may explain 
why central infusion of Kp fails to advance the onset of the LH 
surge in either naturally cycling or ovariectomized estradiol-
supplemented female rodents (154, 155). Finally, the stimulatory 
and synchronizing effects of Kp on GnRH release are reduced in 
preoptic explants of Bmal1 KO mice (35). Therefore, the circadian 
clock in GnRH neurons may provide a time-keeping mechanism 
to appropriately release GnRH under Kp, and possibly VIP, 
stimulation.
Pituitary Gland and Gonadotroph Cells
The pituitary, as a whole, was among the first peripheral oscilla-
tors found to display strong sustained circadian oscillations with 
a circadian period of about 23.8  h in Per1- or PER2-luciferase 
transgenic rodents (115, 145). It was further established that all 
clock genes expressed a daily rhythm in the whole pituitary but 
with a different profile according to the estrus stage (127, 156). 
The pituitary gland is made of different cell types, which could 
host several circadian oscillators with different phases. Expression 
of all cognate clock genes was identified in the alphaT3-1 gon-
adotroph cell line (147) and GnRH activation was reported to 
selectively increase mPer1 expression in gonadotroph cells (157). 
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Furthermore, the gene coding for the GnRH receptor contains 
non-canonical E-box promoter elements and Bmal1 knockdown 
in a gonadotrope cell line reduces GnRH receptor mRNA (147). 
These studies raised the hypothesis that an intrinsic clock in 
gonadotrophs could directly regulate GnRH signaling and LH 
surge timing. To test this hypothesis, a specific BMAL1 KO dis-
ruption was performed in the gonadotrophs (127). The mutated 
mice still displayed a preovulatory LH surge and estrous cyclicity 
(although with a significant increase in cycle length variance) and 
the average time of puberty and fertility performance was not 
altered. Taken together, these data suggest that the intrinsic clock 
in gonadotroph cells is dispensable for LH surge regulation but 
contributes to estrous cycle robustness (127).
Ovaries
The ovarian circadian clock is very well documented in many 
mammalian and non-mammalian species and its function has 
been thoroughly investigated both in vivo and in vitro (158–161). 
Each cell type of the ovary, including theca cells, granulosa cells, 
and oocytes have a circadian clock (162). Further analyses reported 
that clock gene rhythms are only observed in mature granulosa 
and luteal cells, indicating that these rhythms are activated at a 
specific stage of follicle development, possibly under the control 
of FSH acting as a synchronizer of follicular cell activities (163). 
Ovarian physiology is strongly regulated by gonadotropins, and 
current studies indicate that LH stimulates various clock genes in 
the ovaries (159, 164). Furthermore, the endogenous rhythm of 
Per-driven oscillations in isolated ovaries is significantly shifted 
by LH and FSH indicating that the ovarian circadian clock is 
entrained by hormonal signals from the pituitary (160). Recently, 
a study reported that mice with a conditional KO of Bmal1 in 
steroidogenic cells show severe deficits in implantation success 
and compromised progesterone secretion (165). A previous 
study demonstrated a circadian rhythm in ovarian sensitivity to 
LH with a greater ovarian response at night as compared to day, 
indicating that the ovarian circadian clock may set its responsive-
ness to the LH surge (161). Finally, various ovarian genes, includ-
ing those encoding for the LH receptor and enzymes involved 
in steroid hormone biosynthesis, display circadian rhythms 
in granulosa cells and these rhythms are altered following the 
silencing of Bmal1 expression (163). Altogether, these findings 
indicate that the clock in the ovary may be involved in the timing 
of ovulation, steroid hormone synthesis, and follicular growth 
and differentiation.
Uterus and Oviduct
Global knockout of the Bmal1 or Clock gene disrupts implan-
tation, increases fetal reabsorption during pregnancy, and 
leads to a high rate of full-term pregnancy failures (124, 166). 
Early in 2002, clock genes were found to be expressed in the 
uterus and oviduct of mice (167). Furthermore, the oviduct 
was reported to display a daily rhythm of several clock genes 
and clock-controlled gene (168). In the uterus, the presence 
of sustained endogenous clock oscillations was demonstrated 
in tissue explants of PER2:LUCIFERASE mice (99). These 
uterine oscillations were sustained even during pregnancy 
suggesting that embryos may be submitted to the maternal 
clock in  utero (169). Interestingly, the period of the uterine 
clock oscillations changes according to the estrous stage and it 
is decreased when the tissue is incubated with estradiol (99). 
Additionally, a targeted deletion of Bmal1 in the myometrium 
indicates a role for myometrial Bmal1 in maintaining normal 
timing of parturition (170). Although additional studies are 
required to determine the physiological role of the uterine 
and oviduct clocks, the data obtained so far suggest that the 
developing embryo may be subjected to rhythmic changes 
in the oviduct during transit to the uterus and in the uterus 
during pregnancy.
Shift-work Consequences on 
Reproductive Cycles and Fertility
Shift work
The modern 24-h-functioning society requires that an increas-
ing number of employees work outside of the natural active 
period, in shifted conditions. According to the International 
Labor Organization (ILO; 1990), working in shifts is “a method 
of organization of working time in which workers succeed one 
another at the workplace so that the establishment can operate 
longer than the hours of work of individual workers” at differ-
ent daily and night hours. Under a fixed-shift system, working 
time can be organized in two or three shifts: the early, late, and/
or nightshifts. Under a rotating-shift system, workers might be 
assigned to work shifts that vary regularly over time.
Over the last 20 years in United States, almost 27% of men 
and 16% of women experienced shift work (171). In 2012, 15% 
of French workers, including 9.3% women, were working under 
shift work either occasionally (8%) or permanently (7.4%). An 
increasing number of analyses report that alteration in working 
schedule is often associated with an increased risk of develop-
ing cardiovascular/metabolic/gastrointestinal disorders, some 
types of cancer, and mental disorders including depression and 
anxiety (172–174). Hence, in 2007, shift work was reclassified 
from a possible to a probable human carcinogen (class 2A) by 
the International Agency for Research on Cancer. A French law 
passed on December 20, 2014 listed shift work as a risk factor 
increasing professional arduousness.
Given the importance of the circadian systems in the regula-
tion of female reproduction, and given the fetal exposure to the 
maternal daily rhythms in temperature, substrates, and hormones, 
female shift workers may display reproductive alterations, such as 
an increased risk of irregular menstrual cycles, endometriosis, 
miscarriage, low birth weight, or pre-term delivery (175–177). 
Such disturbances may result from altered SCN clock synchro-
nization with rest-activity and feed-fast cycles and/or internal 
desynchronization amongst peripheral clocks, especially those 
of the reproductive axis. Indeed, a recent study reported that 
peripheral clock genes in lymphocytes of shift workers are strongly 
altered as compared to day workers (178). Additionally, recent 
animal studies have shown that the functioning of fetal clocks 
depends on maternal hormones (179) and possibly feeding and 
activity, then maternal circadian disruption during pregnancy 
may lead to fetal SCN and peripheral clocks desynchronization.
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In addition to the effect of circadian dysregulation, it should 
be kept in mind that shift work-related alterations in other daily 
functions, particularly food intake and sleep, may indirectly 
impact female reproduction. Thus, obesity, which is often 
associated with shift work, has a strong impact on reproductive 
performance (180) and sleep disturbance in prepubertal girls can 
alter estradiol-dependent pubertal development (181).
Modeling Shift work in Rodents
Shift work is a very complex situation and therefore, it is difficult 
to design animal model conditions that mimic human shift work. 
A recent review listed four relevant models that use altered timing 
of food intake, activity, sleep or light exposure, or a combination 
of several (182).
Very few in vivo animal studies have investigated the alteration 
of fertility or the LH surge after a shift in the light/dark cycle or 
a photoperiod change (6, 56, 183). In one study, female Syrian 
hamsters were submitted to a 3-h phase advance or delay (183). 
When the phase advance was applied between 1 and 3 days before 
estrous, the LH surge was not fully resynchronized to the new 
schedule, even after 3 days. However, when hamsters were sub-
mitted to a 3-h phase delay, the LH surge was synchronized to the 
dark onset more rapidly. Similarly, in ovariectomized transgenic 
GnRH-GFP mice, a dark phase advance led to an advance in 
the LH surge (56). When the photoperiod length was modified 
in female hamsters, the timing of the LH surge was shifted in a 
similar manner to the nocturnal onset of locomotor activity (6).
In mice, exposure to either phase advances or delays at the 
beginning and throughout pregnancy leads to a significant 
decrease in pregnancy success (184). Interestingly, an in  vitro 
study analyzed the effect of a 6-h phase advance on endogenous 
circadian oscillation of the SCN and various peripheral clocks 
and found that the ovarian clock was not fully resynchronized 
6 days after the phase shift (185).
Although these few studies indicate that shifts in light/dark 
cycle alter the timing of the preovulatory LH surge and the 
synchrony amongst reproductive clocks, it is obvious that new 
animal studies have to be developed in order to understand 
the mechanisms underlying the various effect of shift work on 
reproduction and fertility in females.
Reproductive Consequence in women  
Under Shift work
A number of studies have investigated the relationship between 
fertility and shift work or night work in women working in phar-
maceutical industries, hospitals, slaughter houses, and canneries 
(175, 178, 186–200). Although human studies are limited in their 
use for understanding causality and underlying mechanisms of 
health consequences of shift work, most of the above studies have 
reported a negative impact of shift work on fertility. However, 
there is a large heterogeneity among these analyses especially 
regarding the fertility criteria examined: body temperature curve, 
menstrual disorders, time to get pregnant, etc. Furthermore, it 
is important to stress that clinical or biological criteria can be 
misinterpreted since irregular cycles, as an indicator of the repro-
ductive axis sensibility to shift work, may have no correlation with 
subfertility and pregnancy capacity (197).
Using body temperature curves to follow menstrual cycles, 
shift work was found to be associated with higher rates of short 
cycles and inadequate luteal phases (188). Furthermore, a higher 
prevalence of menstrual disorders is often found in female shift 
workers as compared to the non-shift workers. For example, in the 
most relevant studies including the largest populations, irregular 
cycles are reported in 12–20% of shift workers and 7–10% in non-
shift workers (175, 192). In a large Danish population (17,531 
daytime workers and 3,907 shift workers), it was reported that 
fixed evening and fixed night female workers took longer to get 
pregnant with adjusted odds ratio around 0.80, compared to 
daytime workers, but there was no unequivocal evidence of a 
causal association between shift work and subfecundity since this 
reduction may be mediated by pregnancy planning bias or dif-
ferential options for sexual contacts (187). Only a few studies have 
examined reproductive hormones with various conclusions. It has 
been reported that FSH and LH levels are not different between 
shift and day workers (190, 192), but a single measurement of LH 
without a gynecologic examination and cycle characterization 
is difficult to interpret. The levels of 17-β-estradiol were found 
to be significantly increased (178, 201) in female shift workers 
possibly due to a prolonged follicular phase (186). Some studies 
have reported no significant relationship between shift work and 
subfertility or dysmenorrhea (196–200). However, among these 
studies, one has only a few women included with a surprising 
35% of control women displaying irregular cycles (196). Another 
study reported no significant subfertility in shift-working women 
1  year after birth control termination but yet, these women 
displayed a delay to get pregnant twice as long compared to the 
day-working group (199).
The pineal hormone melatonin, whose nocturnal production 
is profoundly affected by shifts in light/dark conditions, has been 
proposed to display potential anti-estrogenic effects (202, 203). 
Urinary melatonin excretion tends to be lower with a delayed 
peak of production during shift work (190, 193, 201, 204). The 
combination of inhibition on melatonin secretion with estradiol 
mistiming has been proposed to be involved in the hormone-
related cancers observed in night shift workers (204, 205).
The conflicting results regarding the negative effect of shift 
work on female reproduction probably reflect large differences 
in the shift-work schedules, duration, and age of exposure, with a 
high number of confounding factors (like stress, fatigue, obesity, 
etc.) as well as methodological limitations (206, 207). Despite 
these considerations, cycling disorders should be considered as 
a sensitivity or intolerance to shift work. Shift work during preg-
nancy has adverse effects including increased risk of miscarriage 
(208), although this is somewhat controversial (209). Yet, most 
authors recommend avoiding shift work during pregnancy.
Conclusion
Daily and estrogenic regulations of female reproduction allow 
the timing of ovulation to coincide with optimal reproductive 
tract functioning (oocyte maturation and receptive reproductive 
tract), maximal arousal (general activity and sexual motivation), 
and the best environmental conditions (food resources and stress 
level). These general coordinations confer maximum adaptive 
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advantage to insure the success of this high energy-demanding 
reproductive function. Although the central role of the master 
SCN clock in the daily regulation of the LH surge has been well 
documented, the recent evidence that other peripheral clocks 
are located all along the gonadotropic axis, from Kp and GnRH 
neurons to the ovaries and uterus, raises the question of their 
role in the timing of reproduction. The latest findings indicate 
that these local clocks may optimize circadian cell sensitivity to 
upstream signals and set appropriate timing of the downstream 
reproductive responses. Notably, application of phase shifts leads 
to different rates of clock resynchronization between the SCN 
and reproductive organs, suggesting internal desynchronization 
of the reproductive axis, as seen in other functional axes. In our 
current society, where a significant number of female workers are 
working night or evening shifts, the delicate timing of organiza-
tion in the reproductive network can easily be disrupted. While 
numerous studies have reported negative consequences of shift 
work on metabolic and cardiovascular functions as well as cancer 
occurrence, there are surprisingly few epidemiologic studies in 
humans and mechanistic studies in animal models reporting the 
incidence of shift work on female fertility. Future studies in the 
field should, therefore, investigate the impact of daily rhythm 
alterations, as observed under shift-work conditions, jet lag, or 
sleep disturbance, on reproductive cycle and fertility both in 
animal models and humans.
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